Saul N Weingart

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. doi request reprint Enhancing safety reporting in adult ambulatory oncology with a clinician champion: a practice innovation
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA saul
    J Nurs Care Qual 24:203-10. 2009
  2. doi request reprint Clinicians' assessments of electronic medication safety alerts in ambulatory care
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA
    Arch Intern Med 169:1627-32. 2009
  3. ncbi request reprint Patient-reported safety and quality of care in outpatient oncology
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, USA
    Jt Comm J Qual Patient Saf 33:83-94. 2007
  4. pmc Factors associated with pain among ambulatory patients with cancer with advanced disease at a comprehensive cancer center
    Sherri O Stuver
    Dana Farber Cancer Institute, Boston, MA 02215, USA
    J Oncol Pract 8:e17-23. 2012
  5. doi request reprint Medication errors involving oral chemotherapy
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Cancer 116:2455-64. 2010
  6. doi request reprint A longitudinal study of pain variability and its correlates in ambulatory patients with advanced stage cancer
    Junya Zhu
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, Massachusetts 02215 5450, USA
    Cancer 118:6278-86. 2012
  7. pmc Incidence of severe pain in newly diagnosed ambulatory patients with stage IV cancer
    Thomas Isaac
    Dana Farber Cancer Institute, Boston, MA, USA
    Pain Res Manag 17:347-52. 2012
  8. ncbi request reprint Using a patient internet portal to prevent adverse drug events: a randomized, controlled trial
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, Massachusetts, USA
    J Patient Saf 9:169-75. 2013
  9. pmc Hospitalized patients' participation and its impact on quality of care and patient safety
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Int J Qual Health Care 23:269-77. 2011
  10. doi request reprint An empirical model to estimate the potential impact of medication safety alerts on patient safety, health care utilization, and cost in ambulatory care
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA
    Arch Intern Med 169:1465-73. 2009

Detail Information

Publications31

  1. doi request reprint Enhancing safety reporting in adult ambulatory oncology with a clinician champion: a practice innovation
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA saul
    J Nurs Care Qual 24:203-10. 2009
    ..By identifying errors and worrisome conditions, it may help managers identify problems before they lead to harm...
  2. doi request reprint Clinicians' assessments of electronic medication safety alerts in ambulatory care
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA
    Arch Intern Med 169:1627-32. 2009
    ..We undertook a study of respondents' satisfaction with e-prescribing systems, their perceptions of alerts, and their perceptions of behavior changes resulting from alerts...
  3. ncbi request reprint Patient-reported safety and quality of care in outpatient oncology
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, USA
    Jt Comm J Qual Patient Saf 33:83-94. 2007
    ..Although patients suffer the effects of medical errors and iatrogenic injuries, little is known about their ability to recognize these events in ambulatory specialty care...
  4. pmc Factors associated with pain among ambulatory patients with cancer with advanced disease at a comprehensive cancer center
    Sherri O Stuver
    Dana Farber Cancer Institute, Boston, MA 02215, USA
    J Oncol Pract 8:e17-23. 2012
    ..To better understand the burden of pain among patients with advanced cancer, we examined the prevalence of pain reported during office and treatment visits...
  5. doi request reprint Medication errors involving oral chemotherapy
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Cancer 116:2455-64. 2010
    ..Given the expanding use of oral chemotherapies, the authors set out to examine errors in the prescribing, dispensing, administration, and monitoring of these drugs...
  6. doi request reprint A longitudinal study of pain variability and its correlates in ambulatory patients with advanced stage cancer
    Junya Zhu
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, Massachusetts 02215 5450, USA
    Cancer 118:6278-86. 2012
    ....
  7. pmc Incidence of severe pain in newly diagnosed ambulatory patients with stage IV cancer
    Thomas Isaac
    Dana Farber Cancer Institute, Boston, MA, USA
    Pain Res Manag 17:347-52. 2012
    ..Pain is common among cancer patients...
  8. ncbi request reprint Using a patient internet portal to prevent adverse drug events: a randomized, controlled trial
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, Massachusetts, USA
    J Patient Saf 9:169-75. 2013
    ..A module was developed within an electronic patient portal that was designed to enhance communication about medication symptoms and, in turn, reduce ADEs and health-care utilization...
  9. pmc Hospitalized patients' participation and its impact on quality of care and patient safety
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Int J Qual Health Care 23:269-77. 2011
    ..To understand the extent to which hospitalized patients participate in their care, and the association of patient participation with quality of care and patient safety...
  10. doi request reprint An empirical model to estimate the potential impact of medication safety alerts on patient safety, health care utilization, and cost in ambulatory care
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA
    Arch Intern Med 169:1465-73. 2009
    ..Because ambulatory care clinicians override as many as 91% of drug interaction alerts, the potential benefit of electronic prescribing (e-prescribing) with decision support is uncertain...
  11. doi request reprint Can we rely on patients' reports of adverse events?
    Junya Zhu
    Center for Patient Safety, Dana Farber Cancer Institute, The Heller School for Social Policy and Management, Brandeis University, Boston, MA 02215 5450, USA
    Med Care 49:948-55. 2011
    ..Evidence suggests that patients can report a variety of adverse events (AEs) not captured by traditional methods such as a chart review. Little is known, however, about whether patient reports are useful for measuring patient safety...
  12. doi request reprint Comparing clinicians' use of an anticoagulation management service and usual care in ambulatory oncology
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA 02215, USA
    J Oncol Pharm Pract 19:237-45. 2013
    ....
  13. doi request reprint What constitutes patient safety culture in Chinese hospitals?
    Junya Zhu
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA 02215 5450, USA
    Int J Qual Health Care 24:250-7. 2012
    ....
  14. ncbi request reprint The You CAN campaign: teamwork training for patients and families in ambulatory oncology
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, USA
    Jt Comm J Qual Patient Saf 35:63-71. 2009
    ..To examine the potential value of a patient-oriented teamwork intervention, a teamwork training initiative for oncology patients and their families was developed at the Dana-Farber Cancer Institute...
  15. ncbi request reprint Rating recommendations for consumers about patient safety: sense, common sense, or nonsense?
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, USA
    Jt Comm J Qual Patient Saf 35:206-15. 2009
    ..Although many organizations offer advice about the consumer's role in improving patient safety, little is known about these recommendations...
  16. pmc Improving electronic oral chemotherapy prescription: can we build a safer system?
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA
    J Oncol Pract 8:e168-73. 2012
    ..We sought to describe the enhancement, examine its performance to date, and identify opportunities for improvement...
  17. doi request reprint Assessing the quality of pain care in ambulatory patients with advanced stage cancer
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, Massachusetts 02215, USA
    J Pain Symptom Manage 43:1072-81. 2012
    ..Pain is common among patients with advanced cancer despite the dissemination of clinical pain care guidelines...
  18. pmc US Cancer Center Implementation of ASCO/Oncology Nursing Society Chemotherapy Administration Safety Standards
    Saul N Weingart
    Dana Farber Cancer Institute, Boston, MA
    J Oncol Pract 8:7-12. 2012
    ..We sought to assess the implementation status of the ASCO/ONS chemotherapy administration safety standards...
  19. ncbi request reprint Medication reconciliation in ambulatory oncology
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, USA
    Jt Comm J Qual Patient Saf 33:750-7. 2007
    ..Few models for medication reconciliation in ambulatory primary or specialty care have been described, perhaps because of the special challenges posed by this environment...
  20. doi request reprint Assessing the value of electronic prescribing in ambulatory care: a focus group study
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Int J Med Inform 78:571-8. 2009
    ..We sought to understand the reasons for adoption and use of e-prescribing, as well as clinicians' complaints about and perceived benefits of drug allergy and interaction alerts...
  21. doi request reprint Electronic drug interaction alerts in ambulatory care: the value and acceptance of high-value alerts in US medical practices as assessed by an expert clinical panel
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA, USA
    Drug Saf 34:587-93. 2011
    ..Computerized physician order entry systems are known to improve patient safety in acute-care hospitals. However, as clinicians frequently override drug interaction and allergy alerts, their value in ambulatory care remains uncertain...
  22. ncbi request reprint Identifying women at risk of delayed breast cancer diagnosis
    Sherri O Stuver
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, USA
    Jt Comm J Qual Patient Saf 37:568-75. 2011
    ..Delays in breast cancer diagnosis contribute to increased morbidity and mortality. Factors related to the occurrence of delayed diagnosis have not been well studied...
  23. ncbi request reprint Medication safety messages for patients via the web portal: the MedCheck intervention
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Int J Med Inform 77:161-8. 2008
    ..Accordingly, the goal of this study was to learn whether electronic medication safety messages directed to patients can improve communication about medications and identify ADEs...
  24. pmc Process of care failures in breast cancer diagnosis
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, 44 Binney St, Boston, MA, 02115, USA
    J Gen Intern Med 24:702-9. 2009
    ..Process of care failures may contribute to diagnostic errors in breast cancer care...
  25. pmc Medication safety of five oral chemotherapies: a proactive risk assessment
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA
    J Oncol Pract 7:2-6. 2011
    ..Oral chemotherapies represent an emerging risk area in ambulatory oncology practice. To examine the hazards associated with five oral chemotherapies, we performed a proactive risk assessment...
  26. ncbi request reprint Do drug interaction alerts between a chemotherapy order-entry system and an electronic medical record affect clinician behavior?
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA, USA Department of Medicine, Harvard Medical School, Boston, MA, USA
    J Oncol Pharm Pract 20:163-71. 2014
    ..This report summarizes the interactions and analyzes the impact of alerts on clinician behavior...
  27. ncbi request reprint Comparing patient-reported hospital adverse events with medical record review: do patients know something that hospitals do not?
    Joel S Weissman
    Institute for Health Policy, Massachusetts General Hospital, Harvard School of Public Health, Dana Farber Cancer Institute, Boston, Massachusetts, USA
    Ann Intern Med 149:100-8. 2008
    ..Hospitals routinely survey patients about the quality of care they receive, but little is known about whether patient interviews can detect adverse events that medical record reviews do not...
  28. pmc Oral chemotherapy safety practices at US cancer centres: questionnaire survey
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA 02115, USA
    BMJ 334:407. 2007
    ..To characterise current safety practices for the use of oral chemotherapy...
  29. doi request reprint Disparities in evaluation of patients with rectal bleeding 40 years and older
    Helen M Shields
    Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts Division of Gastroenterology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts Electronic address
    Clin Gastroenterol Hepatol 12:669-75; quiz e33. 2014
    ..Rectal bleeding is associated with colorectal cancer. We characterized the evaluation of patients aged 40 years and older with rectal bleeding and identified characteristics associated with inadequate evaluation...
  30. doi request reprint High performance teamwork training and systems redesign in outpatient oncology
    Craig A Bunnell
    Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA
    BMJ Qual Saf 22:405-13. 2013
    ..To address this risk, we developed and piloted a team training initiative in the breast cancer programme at a comprehensive cancer centre...
  31. ncbi request reprint Patient-reported service quality on a medicine unit
    Saul N Weingart
    Center for Patient Safety, Dana Farber Cancer Institute, Boston, MA 02115, USA
    Int J Qual Health Care 18:95-101. 2006
    ..Most studies rely on retrospective consumer surveys rather then more intensive data collection methods, possibly underestimating the incidence of service quality incidents...